GSA CAPITAL PARTNERS LLP - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28
-95.8%
19,366
-92.7%
0.00%
-97.0%
Q2 2023$662
-99.5%
266,017
+2309.1%
0.07%
+266.7%
Q3 2022$138,000
-86.3%
11,042
-94.6%
0.02%
-88.1%
Q2 2022$1,006,000
+143.6%
203,545
+469.5%
0.15%
+118.8%
Q3 2020$413,000
+47.5%
35,742
+40.6%
0.07%
-1.4%
Q1 2020$280,00025,4280.07%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders